Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | B3GNT2 |
| Upstream (Parents) |
|---|
| (<<) ACTN4 → B3GNT2 |
| (<<) ADAM17 → B3GNT2 |
| (<<) ATF2 → B3GNT2 |
| (<<) CEP170 → B3GNT2 |
| (<<) CREB1 → B3GNT2 |
| (<<) EZR → B3GNT2 |
| (<<) ITGB6 → B3GNT2 |
| (<<) MAP3K2 → B3GNT2 |
| (<<) RCAN1 → B3GNT2 |
| (<<) YWHAZ → B3GNT2 |
| Downstream (Children) |
|---|
| B3GNT2 → CASP10 (>>) |
| B3GNT2 → CREB3 (>>) |
| B3GNT2 → DUSP6 (>>) |
| B3GNT2 → DYNC1LI2 (>>) |
| B3GNT2 → EML4 (>>) |
| B3GNT2 → GDNF (>>) |
| B3GNT2 → GNAI3 (>>) |
| B3GNT2 → GNAS (>>) |
| B3GNT2 → GNB1 (>>) |
| B3GNT2 → GNB5 (>>) |
| B3GNT2 → GNG12 (>>) |
| B3GNT2 → IMPA1 (>>) |
| B3GNT2 → LPIN1 (>>) |
| B3GNT2 → MAP3K1 (>>) |
| B3GNT2 → MAP3K11 (>>) |
| B3GNT2 → MLPH (>>) |
| B3GNT2 → SH3GL1 (>>) |
